FORM 6

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a - 16 or 15d - 16 of

the Securities Exchange Act of 1934

 

For the month of May, 2004

Commission File Number: 1-10817

 

CELLTECH GROUP PLC

(Translation of registrant's name into English)

 

208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F X      Form 40-F

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes          No X

 

(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).

 

 

Enclosure: Holding(s) in Company

 

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company
   Celltech Group plc

2. Name of shareholder having a major interest
   Deutsche Bank AG and its subsidiary companies

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18
   As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them
   Unknown

5. Number of shares / amount of stock acquired
   Unknown

6. Percentage of issued class
   Unknown

7. Number of shares / amount of stock disposed
   N/a

8. Percentage of issued class
   N/a

9. Class of security
   Ordinary 50p shares

10. Date of transaction
   Unknown

11. Date company informed
   25 May, 2004

12. Total holding following this notification
   22,071,931

13. Total percentage holding of issued class following this notification
   7.93%

14. Any additional information
   Part of this holding may relate to hedging arrangements for customer transactions.

15. Name of contact and telephone number for queries
   Anita Dowling   Tel: (01753) 777106

16. Name and signature of authorised company official responsible for making this notification
   J A D Slater

Date of notification
   25 May, 2004

The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.

 

 

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company
   Celltech Group plc

2. Name of shareholder having a major interest
   The Capital Group Companies, Inc.

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18
   As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them

   State Street Nominees Ltd

   4,500

   Chase Nominees Ltd

   1,772,403

   Citibank London

   74,300

   Nortrust Nominees

   785,500

   Mellon Nominees (UK) Ltd

   126,900

   State Street Nominees Ltd

   87,000

   Bank of New York Nominees

   2,184,678

   Northern Trust

   513,902

   Chase Nominees Ltd

   637,863

   Midland Bank plc

   18,200

   Bankers Trust

   59,900

   Morgan Guaranty

   93,400

   Nortrust Nominees

   952,138

   Royal Bank of Scotland

   652,800

   State Street Bank & Trust Co

   58,000

   Deutsche Bank AG

   565,500

   HSBC Bank plc

   315,400

   Mellon Bank N.A.

   18,300

   KAS UK

   9,510

   Bank One London

   33,500

   Chase Nominees Ltd

   1,874,891

   Midland Bank plc

   517,400

   Barclays Bank

   474,300

   Citibank London

   23,700

   Brown Bros.

   34,230

   Royal Bank of Scotland

   98,100

   State Street Bank & Trust Co.

   53,400

   Lloyds Bank

   8,800

   Citibank NA

   17,600

   HSBC Bank plc

   70,009

   State Street Nominees Ltd

   753,400

   Bank of New York Nominees

   26,600

   Chase Nominees Ltd

   92,000

   Midland Bank plc

   153,700

   Deutsche Bank Mannheim

   24,000

   Bankers Trust

   4,900

   Citibank London

   21,000

   Nortrust Nominees

   337,323

   Royal Bank of Scotland

   129,500

   State Street Bank & Trust Co

   319,900

   RBSTB Nominees Ltd

   26,300

   HSBC Bank plc

   93,500

5. Number of shares / amount of stock acquired
   N/a

6. Percentage of issued class
   N/a

7. Number of shares / amount of stock disposed
   3,924,523 (since last notification)

8. Percentage of issued class
   1.41%

9. Class of security
   Ordinary 50p Shares

10. Date of transaction
   21 May 2004

11. Date company informed
   25 May 2004

12. Total holding following this notification
   14,118,247

13. Total percentage holding of issued class following this notification
   5.07%

14. Any additional information
   -

15. Name of contact and telephone number for queries
   Anita Dowling   01753 777106

16. Name and signature of authorised company official responsible for making this notification
   J A D Slater

Date of notification
   25 May 2004

The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

                                                                                                                                                           CELLTECH GROUP PLC
                                                                                                                                                           (Registrant)

 

                                                                                                                                                           By: /s/ PETER ALLEN       
                                                                                                                                                           Peter Allen
                                                                                                                                                           Chief Financial Officer

 

Dated: 25 May 2004